Mountain View, CA, February 13, 2006
IMPAC Medical Systems,
Inc., part of the Elekta Group and a leading provider of
information technology solutions for pathology and oncology,
today introduces PowerPath version 9.0 anatomic pathology
information system. New features in version 9.0 include CAP
Protocol Worksheet support with SNOMED CT resulting – which
assists with ACS and CAP regulatory compliance, enhanced GYN
Cytology Reporting with HPV reflex testing, an advanced case
search tool, and laboratory worklist enhancements. PowerPath
provides unmatched performance in managing laboratories that
offer surgical pathology, cytopathology, dermatopathology, and
autopsy services.
The new CAP Protocol Worksheets, designed to meet the
requirements of the American College of Surgeons, allows the
user to advance effortlessly through each CAP cancer worksheet,
selecting data responses that are written to the patient report
and stored discretely for easy retrieval. The CAP data elements
are linked to SNOMED CT codes that can be transmitted through a
results interface.
PowerPath version 9.0 also includes an enhanced GYN Cytology
Reporting tool with configurable HPV Reflex Testing for pap
smears. This allows facility-specific or
referring-physician-specific rules for the type of pap results
that require HPV follow-up tests.
In addition, IMPAC is introducing new optional modules and
interfaces that are compatible with version 9.0, including
Immunohistochemistry Resulting, Enhanced Outreach Reporting,
advanced histology barcoding, and a cancer registry interface.
These optional modules streamline resulting, increase report
format options including color-coded body site maps for GI and
prostate specimens, and facilitate specimen tracking to improve
patient safety.
“This is a major release with many new features, enhancements
and options,” stated George Rugg, vice president for IMPAC’s
Laboratory Systems group. “We have worked very closely with
customers and industry leaders to bring this new functionality
to the lab, and we are confident our users will be pleased with
the results.”
Demonstrations of PowerPath version 9.0 will be available at
IMPAC’s booth at the annual meeting of the United States and
Canadian Academy of Pathology (USCAP) in Atlanta, GA from
February 13-15, 2006, Lab InfoTech Summit in Las Vegas, NV from
March 1-3, 2006 and at CLMA/ThinkLab in Charlotte, NC from March
19-21, 2006. Further information can be found online at
www.impac.com/pathology.
********
For more information, please contact:
Media Inquiries:
Lorna Murdock, Marketing Communications Manager, IMPAC Medical
Systems, Inc.
Tel: +1 650-623-8937, e-mail: pr@impac.com
Product Inquiries:
Julie DeSantis, LIS Market Manager, IMPAC Medical Systems, Inc.
Tel: +1 408-362-2267, e-mail: jdesantis@impac.com
Investor Enquiries:
International: Peter Ejemyr, Group VP Corporate Communications,
Elekta AB
Tel: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
United States: Lars Jonsteg, VP Investor Relations North
America, Elekta Inc.
Tel: +46 708-783 735, e-mail: lars.jonsteg@elekta.com
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., an Elekta company, provides
healthcare information technology (IT) solutions that streamline
clinical and business operations across the spectrum of cancer
care. IMPAC’s open integration to multiple healthcare data and
imaging systems offers oncology-specific patient charting and
practice management, as well as best-of-breed systems for
anatomic pathology, clinical laboratory, and cancer registry.
With products that are used in association with diagnosis and
treatment environments through long-term follow-up, IMPAC
provides a comprehensive oncology management solution that helps
improve overall communication, process efficiency, and the
quality of patient care. For more information about IMPAC
products and services, please call 888-GO-IMPAC or visit
www.impac.com.
About
Elekta
Elekta is an international medical-technology Group, providing
meaningful clinical solutions, comprehensive information systems
and services for improved cancer care and management of brain
disorders. All of Elekta’s solutions employ non-invasive or
minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. With
approx. 1700 employees, Elekta’s corporate headquarters is
located in Stockholm, Sweden and the company is listed on the
Stockholm Stock Exchange under the ticker EKTAb. For more
information about Elekta’s products or services, please visit
www.elekta.com.. |
|
Lorna Murdock
Marketing Communications Manager
IMPAC Medical Systems, Inc.
650-623-8937
pr@impac.com
|
